ArticleCancer cell2022

Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients.

Muhammad Bilal Abid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.